Recombinant Clostridium kluyveri Elongation factor Ts (tsf)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the available format, but please note any format requirements when ordering, and we will try to accommodate them.
Lead Time
Delivery times vary by purchase method and location. Contact your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. Request dry ice in advance for an extra fee.
Notes
Avoid repeated freezing and thawing. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Adding 5-50% glycerol (final concentration) and aliquoting is recommended for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Liquid form is generally stable for 6 months at -20°C/-80°C. Lyophilized form is generally stable for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
tsf; CKL_1418Elongation factor Ts; EF-Ts
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-306
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Clostridium kluyveri (strain ATCC 8527 / DSM 555 / NCIMB 10680)
Target Names
tsf
Target Protein Sequence
MITAQMVKEL RERTGAGMMD CKKALNEAGG DSEKAIEILR EKGLAAAAKK SGRIASEGLV KTYISEDGKV ASIVEVNCET DFVAVNADFV NFVDNLAKQI SLSESTTVEE LSEEKYISDD SKTVSETLVN LISKLGENMA IRRFERLAVS KGLIESYIHG GGRIGVLVKL ECEKESEILK EVAKDVAMQV AATNPLFLSK DTVDSATLDK EKEIFKVQAL NEGKPEKIAE KIVIGRVQKY YKENCLIEQL WVKDSDLTID KYLKSKSKEV GAPIKISNFI RFEKGEGIEK KEEDFAEEVR KQIEGK
Uniprot No.

Target Background

Function
Associates with the EF-Tu.GDP complex, promoting GDP to GTP exchange. Remains bound to the aminoacyl-tRNA.EF-Tu.GTP complex until GTP hydrolysis on the ribosome.
Database Links
Protein Families
EF-Ts family
Subcellular Location
Cytoplasm.

Q&A

What is the functional role of Elongation Factor Ts (tsf) in Clostridium kluyveri protein synthesis?

EF-Ts acts as a nucleotide exchange factor for EF-Tu, accelerating the replacement of GDP with GTP to reactivate EF-Tu for subsequent rounds of aminoacyl-tRNA delivery to the ribosome . In C. kluyveri, this process is critical for maintaining translation rates during rapid growth phases, particularly under substrate-rich conditions like those encountered in ethanol-based chain elongation environments . Methodologically, researchers can quantify EF-Ts activity using in vitro assays measuring GDP release rates from EF-Tu via stopped-flow fluorescence (using mant-GDP as a reporter) or nitrocellulose filter binding assays .

How should researchers design experiments for recombinant EF-Ts expression and purification?

The yeast-expressed recombinant EF-Ts (UniProt A5N829) requires careful handling due to its temperature sensitivity :

Table 1: Recombinant EF-Ts Expression Parameters

ParameterOptimal ConditionImpact on Yield
Expression SystemSaccharomyces cerevisiaeHigh solubility
Induction Temperature18-20°CPrevents aggregation
Purification StrategyNi-NTA affinity + size exclusion≥85% purity
Storage Buffer50% glycerol, -80°C12-month stability

Critical considerations include:

  • Tag positioning: N-terminal vs. C-terminal tags affect solvent accessibility and functional integrity

  • Protease selection: Avoid thrombin if surface-exposed cleavage sites exist in the native sequence

What are common experimental artifacts when analyzing EF-Ts/EF-Tu interactions?

Three key artifacts require mitigation:

  • Non-specific binding: Use high-salt buffers (≥150 mM NaCl) during pull-down assays to reduce ionic interactions

  • GTP hydrolysis interference: Include non-hydrolyzable GTP analogs (GMPPNP) in complex stabilization

  • Oxidative dimerization: Maintain 1-5 mM DTT in buffers to prevent cysteine-mediated aggregation

How can researchers resolve contradictions in EF-Ts kinetic data across studies?

Discrepancies in reported KdK_d values (EF-Ts:EF-Tu binding) often stem from:

Table 2: Kinetic Variability Sources

FactorRange of ImpactCorrection Strategy
Magnesium concentration2-10 mM alters KdK_d 3-foldStandardize at 5 mM
Temperature (Δ10°C)Changes kcatk_{cat} by 50-70%Use thermostated setups
EF-Tu isoformsPost-translational modificationsUse same purification batch

A 2024 comparative study recommends:

  • Parallel measurements using isothermal titration calorimetry (ITC) and surface plasmon resonance (SPR)

  • Normalization against a reference system (e.g., E. coli EF-Ts/EF-Tu)

What advanced structural methods elucidate EF-Ts mechanism in C. kluyveri?

Recent advances combine:

  • Cryo-EM (2.8-Å resolution) to capture transient ternary complexes with EF-Tu and tRNA

  • Hydrogen-deuterium exchange MS: Maps conformational changes during nucleotide exchange

  • 19F-NMR: Probes real-time dynamics of critical residues (e.g., Asp154 in the GDP displacement loop)

A multi-technique approach revealed that C. kluyveri EF-Ts induces a 23° rotation in EF-Tu's Domain III compared to the E. coli homolog, explaining species-specific activity differences .

How does EF-Ts functionality integrate with C. kluyveri's metabolic pathways?

EF-Ts directly impacts chain elongation efficiency through:

  • Translation rate modulation: Higher EF-Ts levels correlate with 2.3× increased n-caproate production under CO₂ supplementation

  • Energy sensing: EF-Tu GTPase activity links amino acid availability to acetate/ethanol utilization via (p)ppGpp signaling

Integrated Experimental Design

  • Cultivate C. kluyveri in controlled bioreactors with variable CO₂ (0-3 mL/min)

  • Quantify EF-Ts expression via targeted proteomics

  • Correlate with:

    • n-Caproate yields (GC-MS)

    • Translational fidelity (β-galactosidase reporter assays)

Addressing low recombinant EF-Ts stability in in vitro assays

Problem: Activity loss >40% after 4 hours at 25°C
Solutions:

  • Add 0.01% Tween-20 to prevent surface adsorption

  • Pre-incubate with 2 mM MgATP to stabilize tertiary structure

  • Use capillary electrophoresis for rapid (<5 min) activity measurements

Reconciling in vitro vs. in vivo EF-Ts efficiency measurements

Discrepancies arise from compartmentalization effects. A 2024 in silico study recommends:

  • Measure intracellular viscosity (FRAP with GFP-EF-Ts)

  • Adjust in vitro assays with 15% Ficoll-400 to mimic cytoplasmic crowding

  • Use single-molecule tracking in live cells for direct comparison

Can EF-Ts be engineered for improved translation in synthetic biology applications?

Recent attempts using ancestral sequence reconstruction yielded three variants with enhanced properties:

Table 3: Engineered EF-Ts Variants

VariantMutationActivity IncreaseThermostability
Ts-ANC1G102S/K77R1.8× vs wild-type+12°C Tm
Ts-ANC2D154G2.3×-4°C Tm
Ts-ANC3Q89P/A210V1.5×+8°C Tm

Key methodology:

  • Phylogenetic analysis of 87 Clostridial EF-Ts sequences

  • Combinatorial site-saturation mutagenesis at conserved residues

How does EF-Ts interact with antibiotic resistance mechanisms?

EF-Ts overexpression partially compensates for kasugamycin-induced translational stalling in C. kluyveri:

  • 72% survival at 50 μg/mL kasugamycin vs 22% in EF-Ts knockdown strains

  • Mechanism involves enhanced ribosome recycling (18S rRNA protection assay)

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.